MSA to Attend the 9th Annual NIH Counter Act Conference

June 9, 2015

During the week of June 15-17th MSA will  be present at  the  Annual NIH Counter Act Conference being held at the New World Trade Center In New York City.  This event brings together NIH sponsored researchers from around the country to report on  progress towards the development of new drugs and treatments for potential chemical and biological agents. MSA will join past and current colleagues at this conference which is being hosted this year by Rutgers University’s Schools of Medicine and Pharmacy, New York Medical College,  The New York Academy of Sciences and the National Institutes of Health.

MSA News

Internship Experience Reflection – Kaitlyn Wylie

I never thought my first job would be in the biotechnology and pharmacy industry, let alone with such a passionate…

Read More

MesaGreen Pharmaceutical Company Files an Investigational New Animal Drug Application

FREDERICK, MD.  Nov. 10, 2022—MesaGreen Pharmaceutical Company announced today that the company has filed an Investigational New Animal Drug (INAD)…

Read More

Mesa Science Associates Receives Grant to Begin Study of a Treatment for Marfan Syndrome

Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of…

Read More